• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Durata Therapeutics Inc

+ Add to Watchlist

DRTX:US

15.3100 USD 0.0900 0.58%

As of 10:17:01 ET on 08/21/2014.

Snapshot for Durata Therapeutics Inc (DRTX)

Open: 15.4500 Day's Range: 15.3000 - 15.8099 Volume: 59,563
Previous Close: 15.4000 52wk Range: 8.0100 - 18.1700 1-Yr Rtn: +86.29%

Stock Chart for DRTX

No chart data available.
  • DRTX:US 15.3000
  • 1D
  • 1M
  • 1Y
15.4000
Interactive DRTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DRTX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.2956
Est. EPS (USD) (12/2014) -2.7480
Est. PEG Ratio -
Market Cap (M USD) 412.37
Shares Outstanding (M) 26.78
30 Day Average Volume 380,316
Price/Book (mrq) 150.6527
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DRTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DRTX

Durata Therapeutics, Inc. develops, acquires, and commercializes therapeutics for the treatment of infectious diseases. The Company focuses on antibiotic treatments for acute bacterial skin and skin structure infections for the specialist physician market.

Paul R EdickChief Executive OfficerCorey N FishmanCFO/COO/Treasurer/Secretary
John P ShannonChief Commercial OfficerMichael W DunneChief Medical Officer
More Company Profile & Key Executives for DRTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil